Editorial: Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions
Why the randomized controlled trial is still at the apex and the gold standard for evaluating new medical and surgical interventions
Authors
- Søren Overgaard (ORCID: https://orcid.org/0000-0001-6829-4787)
- Aleksi Reito (ORCID: https://orcid.org/0000-0002-6903-6461)
Institutions
- Bispebjerg Hospital (DK)
- Coxa Hospital (FI)
- Tampere University (FI)
Publication Details
- Journal
- Acta Orthopaedica
- Published
- 2025-11-25
- DOI
- https://doi.org/10.2340/17453674.2025.44947
- Primary Topic
- Meta-analysis and systematic reviews
- Type
- article
- Field-Weighted Citation Impact
- 0.00